Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 8/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.43 |
| ▸ | BAX | Q07812 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.40 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21174882 | 0.83 | LTA4H (0.48) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL94228 | 0.83 | ESR1 (0.39) | TSHRNR1H2 | |
| SCHEMBL16521498 | 0.81 | ESR1 (0.38) | TSHRNR1H2MEN1KMT2A | |
| SCHEMBL8992173 | 0.81 | ESR1 (0.38) | TSHRNR1H2MEN1KMT2A | |
| SCHEMBL18096779 | 0.79 | LTA4H (0.58) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL10945038 | 0.79 | LTA4H (0.57) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL8954924 | 0.79 | LTA4H (0.57) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL9702208 | 0.78 | LTA4H (0.50) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL3972186 | 0.78 | LTA4H (0.56) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL1929693 | 0.78 | LTA4H (0.56) | LTA4HTSHRNR1H2BAXMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10889690-B2 | Siloxane monomers, their polymerization and uses thereof | INKRON OY (FI) | 2021-01-12 | — | — | US | disclosed |
| US-10435420-B2 | High-RI siloxane monomers, their polymerization and use | INKRON OY (FI) | 2019-10-08 | — | — | US | disclosed |
| US-20190225756-A1 | Siloxane monomers, their polymerization and uses thereof | INKRON OY (FI) | 2019-07-25 | — | — | US | disclosed |
| CN-109715635-A | Siloxane monomers, polymerization and use thereof | 英克伦股份有限公司 | 2019-05-03 | — | — | CN | disclosed |
| US-20180079761-A1 | High-RI siloxane monomers, their polymerization and use | INKRON OY (FI) | 2018-03-22 | — | — | US | disclosed |
| US-20180079761-A1 | High-RI siloxane monomers, their polymerization and use | INKRON OY (FI) | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10435420-B2 | High-RI siloxane monomers, their polymerization and use | IPO9, PPOX, PPID | LTA4H 1437/4885TSHR 4556/4885NR1H2 407/4885 |
| US-20180079761-A1 | High-RI siloxane monomers, their polymerization and use | IPO9, PPOX, PPID | LTA4H 1437/4885TSHR 4556/4885NR1H2 407/4885 |
| US-10889690-B2 | Siloxane monomers, their polymerization and uses thereof | PPOX, PPID, PLOD2 | LTA4H 1094/4885TSHR 4777/4885NR1H2 1018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.